Analysts’ downgrades for Tuesday, July 18th:

Cabot Oil & Gas Corporation (NYSE:COG) was downgraded by analysts at Williams Capital from a buy rating to a hold rating. They currently have $30.00 price target on the stock.

FMC Corporation (NYSE:FMC) was downgraded by analysts at Seaport Global Securities from a buy rating to a neutral rating.

NRG Yield (NYSE:NYLD) was downgraded by analysts at Deutsche Bank AG from a buy rating to a hold rating.

QEP Resources (NYSE:QEP) was downgraded by analysts at Deutsche Bank AG from a buy rating to a hold rating.

Stemline Therapeutics (NASDAQ:STML) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Stemline Therapeutics, Inc. is a biopharmaceutical company developing oncology therapeutics that target cancer stem cells and tumor bulk. The company is developing SL-401, a biologic-drug conjugate, for relapsed or refractory acute myeloid leukemia; and SL-701, a synthetic peptide vaccine, for pediatric and adult high-grade gliomas. Stemline Therapeutics, Inc. is based in New York. “

SPDR MSCI Europe Energy UCITS ETF (NYSE:STN) (TSE:STN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Stantec Inc. provides professional consulting services in planning, engineering, architecture, interior design, landscape architecture, surveying and geomatics. It also provides professional consulting services in environmental sciences, project management, and project economics for infrastructure and facilities projects. Its services include, or relate to, the development of conceptual plans, zoning approval of design infrastructure, transportation planning, traffic engineering, landscape architecture, urban planning, design construction review and surveying. It provides knowledge-based solutions for infrastructure and facilities projects through value-added professional services principally under fee-for-service agreements with clients. Stantec Inc. is headquartered in Edmonton, Canada. “

Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland. “

Sykes Enterprises, (NASDAQ:SYKE) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Sykes Enterprises, Inc. is a leader in providing vertically integrated technology-based solutions through an integrated strategy combining its information technology services with an emerging e-commerce platform. Sykes’ continues to leverage its position as a leading provider of information technology services by assisting its clients in capitalizing on the growth of e-commerce over the Internet. Sykes’ e-commerce service platform enables it to comprehensively continue to expand by serving as a single-source provider of Internet-based technology solutions. “

Synthetic Biologics (NYSEMKT:SYN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan. “

Synthetic Biologics (NYSEMKT:SYN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan. “

TransAlta Corporation (NYSE:TAC) (TSE:TA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “TransAlta is Canada’s largest non-regulated electric generation and marketing company. “

Trend Micro (OTCMKTS:TMICY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Trend Micro Incorporated is engaged in providing endpoint, messaging and Web security software and services. It develops security solutions that protects against a wide range of insidious threats and combined attacks including viruses, spam, phishing, spyware, botnets, and other Web attacks, including data-stealing malware. With Trend Micro, Smart Protection Network, the Company combines Internet-based technologies with smaller, lighter weight clients to stop threats. The Company operates a global network of datacenters combined with automated and manual threat correlation systems to provide customers with a real-time feedback loop of round-the-clock threat intelligence and protection. It helps in exchanging digital information by offering a comprehensive array of customizable solutions to enterprises, small and medium businesses, individuals, service providers and OEM partners. Trend Micro Incorporated is headquartered in Tokyo, Japan. “

Receive News & Ratings for Cabot Oil & Gas Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Oil & Gas Corporation and related companies with MarketBeat.com's FREE daily email newsletter.